StockData
Evotec SE logo

Evotec SE (EVO) stock

EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 4/30
$1.46−0.02 (-1.35%)

Close on Nov 18, 2026Market cap $519.11MP/E –Yield –

Evotec shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 178M, up 0.2% from the year before. The highest annual figure on record is 178M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025178M+0.2%
FY2024Dec 31, 2024177M+0.2%
FY2023Dec 31, 2023177M+0.1%
FY2022Dec 31, 2022177M+6.2%
FY2021Dec 31, 2021166M+8.2%
FY2020Dec 31, 2020154M+2.7%
FY2019Dec 31, 2019150M–

More Evotec figures

See a number that looks wrong?